Summary

Marksans Pharma Ltd. has announced its Q1 2025 financial results with a significant increase in revenue. The company's revenue for the quarter ended June 30, 2025, stands at INR 3,197.34 million, marking an increase of 11.74% from the same period last year. The company's profitability, margins, and other key financial indicators are detailed in the financial statements.

Key Highlights

1. 1

   Q1 2025 revenue stands at INR 3,197.34 million, marking an increase of 11.74% from the same period last year

2. 2

   Profitability, margins, and other key financial indicators are detailed in the financial statements

3. 3

   The company's financial statements have been reviewed by M/s. MSKA & Associates, Chartered Accountants